Repligen Corp (NASDAQ:RGEN)

Wednesday’s trading has closed, but RGEN is being traded in the after-hours session. After-Hours quote »
Data as of 3:59pm ET
 +0.37 / +1.63%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Repligen Corp. is a life sciences company, which focuses on the development, production and commercialization of products used in the process of manufacturing biological drugs. The company also manufactures Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. The company has developed and markets a series of OPUS line of pre-packed """"plug-and-play"""" chromatography columns used for biologics purification and sells test kits to ensure final product quality. Repligen was founded by Alexander Rich in May 1981 and is headquartered in Waltham, MA.

Contact Information

Repligen Corp.
41 Seyon Street
Waltham Massachusetts 02453
P:(781) 250-0111
Investor Relations:
(781) 419-1881



Mutual fund holders46.05%
Other institutional42.29%
Individual stakeholders16.39%

Top Executives

Walter C. HerlihyPresident, CEO, Treasurer, Director & CAO
Tony J. HuntChief Operating Officer
Jon K. SnodgresChief Financial Officer
James R. RuscheSenior Vice President-Research & Development
Howard BenjaminVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.